HealthXenon pauses new enrollment in depression drug trials over side-effect concerns
Xenon Pharmaceuticals said Thursday it had temporarily stopped enrolling new patients in clinical studies of its experimental treatment for major and bipolar depression after reports of mental and nervous-system-related side effects.
R
Xenon pauses new enrollment in depression drug trials over side-effect concerns
Health